Tender workspace
Tender Invitation for the Supply of Tofacitinib (Citrate) TabletsOriginal
Share tender
Hospital Authority · Tender Invitation for the Supply of Tofacitinib (Citrate) Tablets · Contract / tender number: HAHO(S)/T/26-D084 · Closed · Closing date: 30 October 2026 (12:00 noon Hong Kong time)
Tender information
- Contract / tender number
- HAHO(S)/T/26-D084
- Closing date / Award
- 30 October 2026 (12:00 noon Hong Kong time)
- Contractor
- —
- Amount
- —
- Issuing organisation
- 醫院管理局 Hospital Authority
- Update
- 31/10/2026 01:02:50
TENDER BRIEF · WITH SOURCES
Know the requirements. Plan your next step.
Hospital Authority Head Office Tender HAHO(S)/T/26-D084 for the supply of two Tofacitinib (Citrate) Tablets: 5mg immediate-release tablets and 11mg extended-release tablets. The excerpts provided state that a bioequivalence study report must be submitted (against Xeljanz／Xeljanz XR or a brand that has been used by the Authority through Bulk Supplies Contracts, and in accordance with WHO guidelines), and that the offer must remain valid for not less than 270 days after the Tender Closing Date. Tender submission requires two hard copies in a sealed plain envelope, together with a CD-rom containing Tenderer’s Schedules B1 to B4 in searchable PDF format. Closing: 2026-10-30 12:00 noon (Hong Kong Time).
AI summary of the official notice and document excerpts obtained. The complete tender pack and all addenda have not been verified. Check the original terms.
- Closing Date and Time
- 2026-10-30 12:00 noon (Hong Kong Time)Official source ↗Official source ↗
- Tender Method
- Open tender (Hospital Authority Head Office)Official source ↗
Scope of Work／Supply
Item 1: Tofacitinib (Citrate) Tablet 5mg, each tablet containing the equivalent of 5mg Tofacitinib; for loose pack, not more than 500 tablets per box/bottle.Official source ↗
Item 2: Tofacitinib (Citrate) Extended Release Tablet 11mg, each tablet containing the equivalent of 11mg Tofacitinib, in blister or strip pack.Official source ↗
The quantity table has multiple quantity columns for each item (Item 1 first column 350,000 tablets; Item 2 first column 4,550 tablets); the excerpts do not indicate the relationship between the columns, and they must noOfficial source ↗
Qualification Thresholds
A bioequivalence study report must be submitted, compared with the specified brand (Item 1: Xeljanz; Item 2: Xeljanz XR) or a brand that has been used by the Authority through Bulk Supplies Contracts.Official source ↗
Read the details before you decide.
Sign in free for eligibility, submission requirements, risks and source excerpts.
Sign in free to continueNo subscription required.
Related tenders
Related tenders from the same organisation
Other public records from the same department or category.
- Official sourceExpression of Interest for the Supply and Installation of Laboratory Automation Systems, Preanalytic Modules, Microbiology for Pathology Department of Tseung Kwan O Hospital, Kowloon East Cluster, Hospital AuthorityActive · Tender Notice · 2 November 2026 (12:00 noon Hong Kong time)
- Official sourceTender Invitation for the Supply of Zoledronic Acid Infusion 5mgActive · Tender Notice · 2 November 2026 (12:00 noon Hong Kong time)
- Official sourceTender Invitation for the Supply of Ceftolozane and Tazobactam for InfusionActive · Tender Notice · 2 November 2026 (12:00 noon Hong Kong time)
- Official sourceTender Invitation for the Supply of Linezolid Injection 600mgActive · Tender Notice · 2 November 2026 (12:00 noon Hong Kong time)
- Official sourceTender Invitation for the Provision of Point-of-Care-Test (POCT) Blood Gas Analyzer and Related ServicesActive · Tender Notice · 3 November 2026 (12:00 noon Hong Kong time)
- Official sourceQuotation Invitation for the Provision of Relocation and Re-installation Services for the Existing Sculpture Garden to Lawn Area at Alice Ho Miu Ling Nethersole Hospital, New Territories East Cluster, Hospital AuthorityActive · Tender Notice · 4 November 2026 (12:00 noon Hong Kong time)